Literature DB >> 11157487

The flow cytometric analysis of telomere length in antigen-specific CD8+ T cells during acute Epstein-Barr virus infection.

F J Plunkett1, M V Soares, N Annels, A Hislop, K Ivory, M Lowdell, M Salmon, A Rickinson, A N Akbar.   

Abstract

Acute infectious mononucleosis (AIM) induced by Epstein-Barr virus (EBV) infection is characterized by extensive expansion of antigen-specific CD8+ T cells. One potential consequence of this considerable proliferative activity is telomere shortening, which predisposes the EBV-specific cells to replicative senescence. To investigate this, a method was developed that enables the simultaneous identification of EBV specificity of the CD8+ T cells, using major histocompatibility complex (MHC) class I/peptide complexes, together with telomere length, which is determined by fluorescence in situ hybridization. Despite the considerable expansion, CD8+ EBV-specific T cells in patients with AIM maintain their telomere length relative to CD8+ T cells in normal individuals and relative to CD4+ T cells within the patients themselves and this is associated with the induction of the enzyme telomerase. In 4 patients who were studied up to 12 months after resolution of AIM, telomere lengths of EBV-specific CD8+ T cells were unchanged in 3 but shortened in one individual, who was studied only 5 months after initial onset of infection. Substantial telomere shortening in EBV-specific CD8+ T cells was observed in 3 patients who were studied between 15 months and 14 years after recovery from AIM. Thus, although telomerase activation may preserve the replicative potential of EBV-specific cells in AIM and after initial stages of disease resolution, the capacity of these cells to up-regulate this enzyme after restimulation by the persisting virus may dictate the extent of telomere maintenance in the memory CD8+ T-cell pool over time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157487     DOI: 10.1182/blood.v97.3.700

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Improved procedure for the measurement of telomere length in whole cells by PNA probe and flow cytometry.

Authors:  M Carbonari; D Mancaniello; M Cibati; A Catizone; M Fiorilli
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

2.  A robust method for production of MHC tetramers with small molecule fluorophores.

Authors:  Vasanthi Ramachandiran; Vitalii Grigoriev; Lan Lan; Eugene Ravkov; Suzanne A Mertens; John D Altman
Journal:  J Immunol Methods       Date:  2006-09-22       Impact factor: 2.303

Review 3.  Telomere and adaptive immunity.

Authors:  Nan-ping Weng
Journal:  Mech Ageing Dev       Date:  2007-12-08       Impact factor: 5.432

4.  Reduced telomerase activity in human T lymphocytes exposed to cortisol.

Authors:  Jenny Choi; Steven R Fauce; Rita B Effros
Journal:  Brain Behav Immun       Date:  2008-01-25       Impact factor: 7.217

5.  Assessment of telomere length, phenotype, and DNA content.

Authors:  Ingrid Schmid; Beth D Jamieson
Journal:  Curr Protoc Cytom       Date:  2004-09

6.  Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length.

Authors:  Xinglei Shen; Juhua Zhou; Karen S Hathcock; Paul Robbins; Daniel J Powell; Steven A Rosenberg; Richard J Hodes
Journal:  J Immunother       Date:  2007-01       Impact factor: 4.456

Review 7.  Telomere length measurement-caveats and a critical assessment of the available technologies and tools.

Authors:  Geraldine Aubert; Mark Hills; Peter M Lansdorp
Journal:  Mutat Res       Date:  2011-06-12       Impact factor: 2.433

8.  Early life infection, but not breastfeeding, predicts adult blood telomere lengths in the Philippines.

Authors:  Dan T A Eisenberg; Judith B Borja; M Geoffrey Hayes; Christopher W Kuzawa
Journal:  Am J Hum Biol       Date:  2017-01-25       Impact factor: 1.937

9.  CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.

Authors:  Matthew Hoare; William T H Gelson; Abhi Das; Jean M Fletcher; Susan E Davies; Martin D Curran; Sarah L Vowler; Mala K Maini; Arne N Akbar; Graeme J M Alexander
Journal:  J Hepatol       Date:  2010-04-22       Impact factor: 25.083

10.  Sleeping beauty system to redirect T-cell specificity for human applications.

Authors:  Sourindra N Maiti; Helen Huls; Harjeet Singh; Margaret Dawson; Matthew Figliola; Simon Olivares; Pullavathi Rao; Yi Jue Zhao; Asha Multani; Ge Yang; Ling Zhang; Denise Crossland; Sonny Ang; Hiroki Torikai; Brian Rabinovich; Dean A Lee; Partow Kebriaei; Perry Hackett; Richard E Champlin; Laurence J N Cooper
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.